Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:2121-2129
Published online before print September 26, 2005, doi: 10.1161/CIRCULATIONAHA.105.544676
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
112/14/2121    most recent
CIRCULATIONAHA.105.544676v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scholz, H.
Right arrow Articles by Halvorsen, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scholz, H.
Right arrow Articles by Halvorsen, B.
Related Collections
Right arrow Lipids
Right arrow Pathophysiology
Right arrow Gene expression

(Circulation. 2005;112:2121-2129.)
© 2005 American Heart Association, Inc.


Coronary Heart Disease

Enhanced Plasma Levels of LIGHT in Unstable Angina

Possible Pathogenic Role in Foam Cell Formation and Thrombosis

Hanne Scholz, MSc; Wiggo Sandberg, MSc; Jan Kristian Damås, MD, PhD; Camilla Smith, MD; Arne K. Andreassen, MD, PhD; Lars Gullestad, MD, PhD; Stig S. Frøland, MD, PhD; Arne Yndestad, PhD; Pål Aukrust, MD, PhD; Bente Halvorsen, MSc, PhD

From the Research Institute for Internal Medicine (H.S., W.S., J.K.D., C.S., S.S.F., A.Y., P.A., B.H.), Department of Cardiology (A.K.A., L.G.), and Section of Clinical Immunology and Infectious Diseases (S.S.F., P.A.), Rikshospitalet University Hospital, Oslo, Norway.

Correspondence to Hanne Scholz, MSc, Research Institute for Internal Medicine, Rikshospitalet University Hospital, University of Oslo, N-0027 Oslo, Norway. E-mail hanne.scholz{at}klinmed.uio.no

Received February 22, 2005; revision received June 3, 2005; accepted July 12, 2005.

Background— Numerous studies have demonstrated the ability of oxidized LDL [(ox)LDL] to promote an inflammatory response in macrophages. Several inflammatory mediators have been reported to increase after oxLDL stimulation of such cells, but their relative importance is still unknown. In the present study, we used microarrays to identify genes in THP-1 macrophages that were upregulated by oxLDL.

Methods and Results— Our main findings were as follows. In a microarray screening experiment, we identified LIGHT, a ligand in the tumor necrosis factor superfamily, as one of the genes that were markedly upregulated in oxLDL-stimulated THP-1 macrophages. We showed significantly raised plasma levels of LIGHT in patients with stable angina (n=40) and particularly in those with unstable angina (n=40) compared with healthy controls (n=20), which underscores the clinical relevance of the in vitro finding. We also showed that LIGHT enhanced lipid accumulation in oxLDL-stimulated THP-1 macrophages, possibly through upregulation of class A scavenger receptor (SR-A). This increased lipid accumulation was accompanied by enhanced expression of tissue factor and plasminogen activator inhibitor-1, as well as enhanced thrombin formation, transforming macrophages into a prothrombotic phenotype. The LIGHT-mediated increase in SR-A, tissue factor, and plasminogen activator inhibitor-1 was also seen in human monocyte-derived macrophages. Finally, the LIGHT-mediated enhancement of SR-A and TF expression appears to involve nuclear factor-{kappa}B activation.

Conclusions— These findings suggest that LIGHT could serve as a molecular link between lipid metabolism, inflammation, and thrombus formation, which are all features of atherosclerotic plaques.


Key Words: angina • inflammation • lipids • thrombosis • macrophage